The expression level of CDK5RAP3 is significantly reduced both in gastric cancer and in GNEC tissues which is correlated with TNM stage, poor prognosis, invasion depth, and lymph node metastasis (16, 24–27, 83). Here, CDK5RAP3 is linked to gastric cancer.